Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA

Clinical trial NCT04319783 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04319783
Sponsor: Trans Tasman Radiation Oncology Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Prostate Carcinoma Cancer of Prostate PSA Castrate Resistant Prostate Cancer

Start date: 2021-06-02
Primary completion: 2026-06-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.